Virtual Patent Marking
The following RxAnte® products, technology or portions thereof (“RxAnte Technology”) are protected in the United States by the US patents specified below. Additional patent applications may be pending.
|RxAnte Technology||US Patent Number|
|RxEffect||U.S. Patent 10,108,975|
|Value of Future Adherence (VFA)||U.S. Patent 10,318,897; andUS Patent 10,707,372|
This page is intended to satisfy virtual patent marking provisions of various jurisdictions, and is intended to serve as notice under 35 U.S.C § 287(a) of the Leahy-Smith America Invents Act, also known as the Patent Reform Act of 2011.
Last Updated: 1/5/2021